nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC47A1—Metformin—type 2 diabetes mellitus	0.188	0.305	CbGbCtD
Famotidine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0727	0.118	CbGbCtD
Famotidine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0618	0.101	CbGbCtD
Famotidine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0618	0.101	CbGbCtD
Famotidine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0581	0.0945	CbGbCtD
Famotidine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0571	0.0928	CbGbCtD
Famotidine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0551	0.0896	CbGbCtD
Famotidine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0317	0.0515	CbGbCtD
Famotidine—CYP2C19—Losartan—type 2 diabetes mellitus	0.029	0.0471	CbGbCtD
Famotidine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000213	0.000712	CcSEcCtD
Famotidine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000213	0.000711	CcSEcCtD
Famotidine—Myalgia—Metformin—type 2 diabetes mellitus	0.000213	0.00071	CcSEcCtD
Famotidine—Chest pain—Metformin—type 2 diabetes mellitus	0.000213	0.00071	CcSEcCtD
Famotidine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000212	0.000707	CcSEcCtD
Famotidine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000212	0.000706	CcSEcCtD
Famotidine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000211	0.000705	CcSEcCtD
Famotidine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00021	0.000701	CcSEcCtD
Famotidine—Nausea—Glipizide—type 2 diabetes mellitus	0.00021	0.000699	CcSEcCtD
Famotidine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000209	0.000699	CcSEcCtD
Famotidine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000209	0.000696	CcSEcCtD
Famotidine—Pain—Gliclazide—type 2 diabetes mellitus	0.000209	0.000696	CcSEcCtD
Famotidine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000209	0.000696	CcSEcCtD
Famotidine—Rash—Glimepiride—type 2 diabetes mellitus	0.000208	0.000693	CcSEcCtD
Famotidine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000207	0.000692	CcSEcCtD
Famotidine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000207	0.000692	CcSEcCtD
Famotidine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000207	0.000691	CcSEcCtD
Famotidine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000207	0.00069	CcSEcCtD
Famotidine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000207	0.00069	CcSEcCtD
Famotidine—Headache—Glimepiride—type 2 diabetes mellitus	0.000206	0.000688	CcSEcCtD
Famotidine—Cough—Irbesartan—type 2 diabetes mellitus	0.000206	0.000687	CcSEcCtD
Famotidine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000206	0.000686	CcSEcCtD
Famotidine—Anaemia—Losartan—type 2 diabetes mellitus	0.000205	0.000685	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000204	0.000681	CcSEcCtD
Famotidine—Agitation—Losartan—type 2 diabetes mellitus	0.000204	0.000681	CcSEcCtD
Famotidine—Oedema—Metformin—type 2 diabetes mellitus	0.000204	0.000681	CcSEcCtD
Famotidine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000204	0.00068	CcSEcCtD
Famotidine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000203	0.000678	CcSEcCtD
Famotidine—Flushing—Ramipril—type 2 diabetes mellitus	0.000203	0.000677	CcSEcCtD
Famotidine—Angioedema—Losartan—type 2 diabetes mellitus	0.000203	0.000677	CcSEcCtD
Famotidine—Infection—Metformin—type 2 diabetes mellitus	0.000203	0.000676	CcSEcCtD
Famotidine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000203	0.000676	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000202	0.000673	CcSEcCtD
Famotidine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000201	0.000671	CcSEcCtD
Famotidine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000201	0.00067	CcSEcCtD
Famotidine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000201	0.00067	CcSEcCtD
Famotidine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000201	0.00067	CcSEcCtD
Famotidine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000201	0.00067	CcSEcCtD
Famotidine—Shock—Metformin—type 2 diabetes mellitus	0.000201	0.00067	CcSEcCtD
Famotidine—Insomnia—Orlistat—type 2 diabetes mellitus	0.0002	0.000668	CcSEcCtD
Famotidine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.0002	0.000668	CcSEcCtD
Famotidine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0002	0.000668	CcSEcCtD
Famotidine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.0002	0.000666	CcSEcCtD
Famotidine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000199	0.000665	CcSEcCtD
Famotidine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000199	0.000664	CcSEcCtD
Famotidine—Syncope—Losartan—type 2 diabetes mellitus	0.000199	0.000664	CcSEcCtD
Famotidine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000199	0.000663	CcSEcCtD
Famotidine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000199	0.000663	CcSEcCtD
Famotidine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000197	0.000658	CcSEcCtD
Famotidine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000196	0.000655	CcSEcCtD
Famotidine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000196	0.000655	CcSEcCtD
Famotidine—Palpitations—Losartan—type 2 diabetes mellitus	0.000196	0.000655	CcSEcCtD
Famotidine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000196	0.000653	CcSEcCtD
Famotidine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000195	0.000652	CcSEcCtD
Famotidine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000195	0.000651	CcSEcCtD
Famotidine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000195	0.000651	CcSEcCtD
Famotidine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000195	0.00065	CcSEcCtD
Famotidine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000195	0.00065	CcSEcCtD
Famotidine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000195	0.00065	CcSEcCtD
Famotidine—Anorexia—Metformin—type 2 diabetes mellitus	0.000195	0.000649	CcSEcCtD
Famotidine—Cough—Losartan—type 2 diabetes mellitus	0.000194	0.000646	CcSEcCtD
Famotidine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000194	0.000646	CcSEcCtD
Famotidine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000193	0.000645	CcSEcCtD
Famotidine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000193	0.000644	CcSEcCtD
Famotidine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000193	0.000643	CcSEcCtD
Famotidine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000193	0.000643	CcSEcCtD
Famotidine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000193	0.000642	CcSEcCtD
Famotidine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000193	0.000642	CcSEcCtD
Famotidine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000192	0.000642	CcSEcCtD
Famotidine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000192	0.000641	CcSEcCtD
Famotidine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000192	0.000639	CcSEcCtD
Famotidine—Constipation—Valsartan—type 2 diabetes mellitus	0.000192	0.000639	CcSEcCtD
Famotidine—Infection—Irbesartan—type 2 diabetes mellitus	0.000191	0.000638	CcSEcCtD
Famotidine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000191	0.000637	CcSEcCtD
Famotidine—Shock—Irbesartan—type 2 diabetes mellitus	0.000189	0.000632	CcSEcCtD
Famotidine—Pain—Orlistat—type 2 diabetes mellitus	0.000189	0.000632	CcSEcCtD
Famotidine—Chest pain—Losartan—type 2 diabetes mellitus	0.000189	0.000631	CcSEcCtD
Famotidine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000189	0.000631	CcSEcCtD
Famotidine—Myalgia—Losartan—type 2 diabetes mellitus	0.000189	0.000631	CcSEcCtD
Famotidine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000189	0.00063	CcSEcCtD
Famotidine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000189	0.000629	CcSEcCtD
Famotidine—Anxiety—Losartan—type 2 diabetes mellitus	0.000188	0.000628	CcSEcCtD
Famotidine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000187	0.000625	CcSEcCtD
Famotidine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000187	0.000624	CcSEcCtD
Famotidine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000186	0.000622	CcSEcCtD
Famotidine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000186	0.000621	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000186	0.00062	CcSEcCtD
Famotidine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000186	0.00062	CcSEcCtD
Famotidine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000185	0.000617	CcSEcCtD
Famotidine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000184	0.000612	CcSEcCtD
Famotidine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000183	0.000611	CcSEcCtD
Famotidine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000183	0.000611	CcSEcCtD
Famotidine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000183	0.000611	CcSEcCtD
Famotidine—Confusional state—Losartan—type 2 diabetes mellitus	0.000183	0.00061	CcSEcCtD
Famotidine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000182	0.000609	CcSEcCtD
Famotidine—Somnolence—Metformin—type 2 diabetes mellitus	0.000181	0.000605	CcSEcCtD
Famotidine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000181	0.000605	CcSEcCtD
Famotidine—Oedema—Losartan—type 2 diabetes mellitus	0.000181	0.000605	CcSEcCtD
Famotidine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000181	0.000604	CcSEcCtD
Famotidine—Infection—Losartan—type 2 diabetes mellitus	0.00018	0.000601	CcSEcCtD
Famotidine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00018	0.000599	CcSEcCtD
Famotidine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00018	0.000599	CcSEcCtD
Famotidine—Shock—Losartan—type 2 diabetes mellitus	0.000178	0.000595	CcSEcCtD
Famotidine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000178	0.000594	CcSEcCtD
Famotidine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000177	0.000592	CcSEcCtD
Famotidine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000177	0.000592	CcSEcCtD
Famotidine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000177	0.000591	CcSEcCtD
Famotidine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000176	0.000589	CcSEcCtD
Famotidine—Fatigue—Metformin—type 2 diabetes mellitus	0.000176	0.000587	CcSEcCtD
Famotidine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000176	0.000587	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000175	0.000585	CcSEcCtD
Famotidine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000175	0.000584	CcSEcCtD
Famotidine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000175	0.000584	CcSEcCtD
Famotidine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000175	0.000584	CcSEcCtD
Famotidine—Agitation—Ramipril—type 2 diabetes mellitus	0.000175	0.000584	CcSEcCtD
Famotidine—Constipation—Metformin—type 2 diabetes mellitus	0.000175	0.000582	CcSEcCtD
Famotidine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000174	0.00058	CcSEcCtD
Famotidine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000173	0.000577	CcSEcCtD
Famotidine—Anorexia—Losartan—type 2 diabetes mellitus	0.000173	0.000576	CcSEcCtD
Famotidine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000173	0.000576	CcSEcCtD
Famotidine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000173	0.000576	CcSEcCtD
Famotidine—Rash—Glyburide—type 2 diabetes mellitus	0.000171	0.000571	CcSEcCtD
Famotidine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000171	0.000571	CcSEcCtD
Famotidine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000171	0.000571	CcSEcCtD
Famotidine—Syncope—Ramipril—type 2 diabetes mellitus	0.000171	0.00057	CcSEcCtD
Famotidine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00017	0.000569	CcSEcCtD
Famotidine—Headache—Glyburide—type 2 diabetes mellitus	0.00017	0.000568	CcSEcCtD
Famotidine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00017	0.000565	CcSEcCtD
Famotidine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000168	0.000561	CcSEcCtD
Famotidine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000168	0.000561	CcSEcCtD
Famotidine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000167	0.000558	CcSEcCtD
Famotidine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000167	0.000558	CcSEcCtD
Famotidine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000167	0.000557	CcSEcCtD
Famotidine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000167	0.000557	CcSEcCtD
Famotidine—Cough—Ramipril—type 2 diabetes mellitus	0.000166	0.000554	CcSEcCtD
Famotidine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000166	0.000554	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000165	0.000551	CcSEcCtD
Famotidine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000165	0.000551	CcSEcCtD
Famotidine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000165	0.00055	CcSEcCtD
Famotidine—Pain—Irbesartan—type 2 diabetes mellitus	0.000165	0.000549	CcSEcCtD
Famotidine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000165	0.000549	CcSEcCtD
Famotidine—Insomnia—Losartan—type 2 diabetes mellitus	0.000164	0.000547	CcSEcCtD
Famotidine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000163	0.000544	CcSEcCtD
Famotidine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000163	0.000543	CcSEcCtD
Famotidine—Urticaria—Metformin—type 2 diabetes mellitus	0.000162	0.000541	CcSEcCtD
Famotidine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000162	0.000541	CcSEcCtD
Famotidine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000162	0.000541	CcSEcCtD
Famotidine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000162	0.000541	CcSEcCtD
Famotidine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000162	0.000539	CcSEcCtD
Famotidine—Nausea—Glyburide—type 2 diabetes mellitus	0.000161	0.000538	CcSEcCtD
Famotidine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000161	0.000538	CcSEcCtD
Famotidine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000161	0.000538	CcSEcCtD
Famotidine—Somnolence—Losartan—type 2 diabetes mellitus	0.000161	0.000537	CcSEcCtD
Famotidine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000161	0.000536	CcSEcCtD
Famotidine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00016	0.000532	CcSEcCtD
Famotidine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000159	0.00053	CcSEcCtD
Famotidine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000159	0.000529	CcSEcCtD
Famotidine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000159	0.000529	CcSEcCtD
Famotidine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000159	0.000529	CcSEcCtD
Famotidine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000158	0.000526	CcSEcCtD
Famotidine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000157	0.000525	CcSEcCtD
Famotidine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000157	0.000523	CcSEcCtD
Famotidine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000157	0.000523	CcSEcCtD
Famotidine—Fatigue—Losartan—type 2 diabetes mellitus	0.000156	0.000521	CcSEcCtD
Famotidine—Oedema—Ramipril—type 2 diabetes mellitus	0.000155	0.000518	CcSEcCtD
Famotidine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000155	0.000518	CcSEcCtD
Famotidine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000155	0.000517	CcSEcCtD
Famotidine—Pain—Losartan—type 2 diabetes mellitus	0.000155	0.000517	CcSEcCtD
Famotidine—Constipation—Losartan—type 2 diabetes mellitus	0.000155	0.000517	CcSEcCtD
Famotidine—Rash—Gliclazide—type 2 diabetes mellitus	0.000154	0.000513	CcSEcCtD
Famotidine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000154	0.000512	CcSEcCtD
Famotidine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000153	0.000511	CcSEcCtD
Famotidine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000153	0.00051	CcSEcCtD
Famotidine—Shock—Ramipril—type 2 diabetes mellitus	0.000153	0.00051	CcSEcCtD
Famotidine—Headache—Gliclazide—type 2 diabetes mellitus	0.000153	0.00051	CcSEcCtD
Famotidine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000152	0.000508	CcSEcCtD
Famotidine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000152	0.000508	CcSEcCtD
Famotidine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000152	0.000508	CcSEcCtD
Famotidine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000151	0.000505	CcSEcCtD
Famotidine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000149	0.000498	CcSEcCtD
Famotidine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000148	0.000494	CcSEcCtD
Famotidine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000148	0.000494	CcSEcCtD
Famotidine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000148	0.000494	CcSEcCtD
Famotidine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000146	0.000488	CcSEcCtD
Famotidine—Asthenia—Metformin—type 2 diabetes mellitus	0.000146	0.000488	CcSEcCtD
Famotidine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000145	0.000483	CcSEcCtD
Famotidine—Pruritus—Metformin—type 2 diabetes mellitus	0.000144	0.000482	CcSEcCtD
Famotidine—Urticaria—Losartan—type 2 diabetes mellitus	0.000144	0.00048	CcSEcCtD
Famotidine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000143	0.000478	CcSEcCtD
Famotidine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000143	0.000478	CcSEcCtD
Famotidine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000142	0.000475	CcSEcCtD
Famotidine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000142	0.000473	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000142	0.000472	CcSEcCtD
Famotidine—Rash—Valsartan—type 2 diabetes mellitus	0.000141	0.000471	CcSEcCtD
Famotidine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000141	0.000471	CcSEcCtD
Famotidine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000141	0.00047	CcSEcCtD
Famotidine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000141	0.000469	CcSEcCtD
Famotidine—Headache—Valsartan—type 2 diabetes mellitus	0.00014	0.000468	CcSEcCtD
Famotidine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00014	0.000466	CcSEcCtD
Famotidine—Rash—Orlistat—type 2 diabetes mellitus	0.00014	0.000466	CcSEcCtD
Famotidine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00014	0.000465	CcSEcCtD
Famotidine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000139	0.000465	CcSEcCtD
Famotidine—Headache—Orlistat—type 2 diabetes mellitus	0.000139	0.000463	CcSEcCtD
Famotidine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000138	0.000461	CcSEcCtD
Famotidine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000138	0.000461	CcSEcCtD
Famotidine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000137	0.000456	CcSEcCtD
Famotidine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000136	0.000454	CcSEcCtD
Famotidine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000135	0.000451	CcSEcCtD
Famotidine—Dizziness—Metformin—type 2 diabetes mellitus	0.000135	0.00045	CcSEcCtD
Famotidine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000134	0.000447	CcSEcCtD
Famotidine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000134	0.000445	CcSEcCtD
Famotidine—Nausea—Valsartan—type 2 diabetes mellitus	0.000133	0.000444	CcSEcCtD
Famotidine—Constipation—Ramipril—type 2 diabetes mellitus	0.000133	0.000443	CcSEcCtD
Famotidine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000132	0.00044	CcSEcCtD
Famotidine—Nausea—Orlistat—type 2 diabetes mellitus	0.000132	0.000439	CcSEcCtD
Famotidine—Asthenia—Losartan—type 2 diabetes mellitus	0.00013	0.000434	CcSEcCtD
Famotidine—Vomiting—Metformin—type 2 diabetes mellitus	0.00013	0.000433	CcSEcCtD
Famotidine—Rash—Metformin—type 2 diabetes mellitus	0.000129	0.000429	CcSEcCtD
Famotidine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000129	0.000429	CcSEcCtD
Famotidine—Pruritus—Losartan—type 2 diabetes mellitus	0.000128	0.000428	CcSEcCtD
Famotidine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000128	0.000427	CcSEcCtD
Famotidine—Headache—Metformin—type 2 diabetes mellitus	0.000128	0.000426	CcSEcCtD
Famotidine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000127	0.000425	CcSEcCtD
Famotidine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000127	0.000424	CcSEcCtD
Famotidine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000124	0.000414	CcSEcCtD
Famotidine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000123	0.000412	CcSEcCtD
Famotidine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000123	0.00041	CcSEcCtD
Famotidine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000123	0.00041	CcSEcCtD
Famotidine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000122	0.000408	CcSEcCtD
Famotidine—Rash—Irbesartan—type 2 diabetes mellitus	0.000121	0.000405	CcSEcCtD
Famotidine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000121	0.000405	CcSEcCtD
Famotidine—Nausea—Metformin—type 2 diabetes mellitus	0.000121	0.000404	CcSEcCtD
Famotidine—Headache—Irbesartan—type 2 diabetes mellitus	0.000121	0.000402	CcSEcCtD
Famotidine—Dizziness—Losartan—type 2 diabetes mellitus	0.00012	0.0004	CcSEcCtD
Famotidine—Vomiting—Losartan—type 2 diabetes mellitus	0.000115	0.000384	CcSEcCtD
Famotidine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000114	0.000382	CcSEcCtD
Famotidine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000114	0.000382	CcSEcCtD
Famotidine—Rash—Losartan—type 2 diabetes mellitus	0.000114	0.000381	CcSEcCtD
Famotidine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000114	0.000381	CcSEcCtD
Famotidine—Headache—Losartan—type 2 diabetes mellitus	0.000114	0.000379	CcSEcCtD
Famotidine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000111	0.000372	CcSEcCtD
Famotidine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00011	0.000367	CcSEcCtD
Famotidine—Nausea—Losartan—type 2 diabetes mellitus	0.000108	0.000359	CcSEcCtD
Famotidine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000106	0.000355	CcSEcCtD
Famotidine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000103	0.000343	CcSEcCtD
Famotidine—Vomiting—Ramipril—type 2 diabetes mellitus	9.88e-05	0.00033	CcSEcCtD
Famotidine—Rash—Ramipril—type 2 diabetes mellitus	9.8e-05	0.000327	CcSEcCtD
Famotidine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000327	CcSEcCtD
Famotidine—Headache—Ramipril—type 2 diabetes mellitus	9.74e-05	0.000325	CcSEcCtD
Famotidine—Nausea—Ramipril—type 2 diabetes mellitus	9.23e-05	0.000308	CcSEcCtD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.25e-05	0.0005	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—COX2—type 2 diabetes mellitus	4.2e-05	0.000494	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC5A2—type 2 diabetes mellitus	4.2e-05	0.000494	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—C3—type 2 diabetes mellitus	4.16e-05	0.000489	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOA6—type 2 diabetes mellitus	4.13e-05	0.000486	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	4.11e-05	0.000483	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	4.06e-05	0.000477	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HSD11B1—type 2 diabetes mellitus	4.06e-05	0.000477	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—UCP2—type 2 diabetes mellitus	4.06e-05	0.000477	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—UCP3—type 2 diabetes mellitus	4.06e-05	0.000477	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IAPP—type 2 diabetes mellitus	4.03e-05	0.000474	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INSR—type 2 diabetes mellitus	4.01e-05	0.000472	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.95e-05	0.000465	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.94e-05	0.000463	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.93e-05	0.000463	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.92e-05	0.000461	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.92e-05	0.000461	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.91e-05	0.000459	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.87e-05	0.000455	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.86e-05	0.000454	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PCK1—type 2 diabetes mellitus	3.82e-05	0.000449	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—C3—type 2 diabetes mellitus	3.78e-05	0.000444	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.75e-05	0.000441	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.74e-05	0.00044	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGDS—type 2 diabetes mellitus	3.72e-05	0.000437	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AANAT—type 2 diabetes mellitus	3.72e-05	0.000437	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.65e-05	0.000429	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.64e-05	0.000428	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.64e-05	0.000428	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.59e-05	0.000422	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HK1—type 2 diabetes mellitus	3.57e-05	0.00042	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.54e-05	0.000417	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	3.54e-05	0.000416	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.53e-05	0.000415	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.53e-05	0.000415	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPD2—type 2 diabetes mellitus	3.53e-05	0.000415	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CDO1—type 2 diabetes mellitus	3.53e-05	0.000415	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.5e-05	0.000411	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.47e-05	0.000408	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.45e-05	0.000406	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.45e-05	0.000406	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—KCNJ11—type 2 diabetes mellitus	3.45e-05	0.000406	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCKR—type 2 diabetes mellitus	3.45e-05	0.000406	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPA—type 2 diabetes mellitus	3.45e-05	0.000406	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HSD3B2—type 2 diabetes mellitus	3.45e-05	0.000406	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	3.45e-05	0.000405	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	3.42e-05	0.000403	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.41e-05	0.000401	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.37e-05	0.000396	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AK1—type 2 diabetes mellitus	3.36e-05	0.000396	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.32e-05	0.000391	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.31e-05	0.00039	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDOB—type 2 diabetes mellitus	3.31e-05	0.000389	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.21e-05	0.000378	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.2e-05	0.000376	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.16e-05	0.000371	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.16e-05	0.000371	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.16e-05	0.000371	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.11e-05	0.000365	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC5A4—type 2 diabetes mellitus	3.1e-05	0.000365	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAT1A—type 2 diabetes mellitus	3.1e-05	0.000365	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.1e-05	0.000364	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.09e-05	0.000364	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GLP1R—type 2 diabetes mellitus	3.08e-05	0.000362	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.03e-05	0.000357	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.01e-05	0.000354	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ND1—type 2 diabetes mellitus	3e-05	0.000353	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPP1R3C—type 2 diabetes mellitus	3e-05	0.000353	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—G6PC—type 2 diabetes mellitus	3e-05	0.000353	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HBA2—type 2 diabetes mellitus	3e-05	0.000353	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ENPP1—type 2 diabetes mellitus	3e-05	0.000353	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.96e-05	0.000348	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.95e-05	0.000347	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCGR—type 2 diabetes mellitus	2.9e-05	0.000341	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.9e-05	0.000341	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.9e-05	0.000341	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A2—type 2 diabetes mellitus	2.87e-05	0.000338	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CPT1A—type 2 diabetes mellitus	2.81e-05	0.000331	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTR—type 2 diabetes mellitus	2.81e-05	0.000331	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.8e-05	0.000329	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NAMPT—type 2 diabetes mellitus	2.76e-05	0.000325	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.75e-05	0.000323	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	2.74e-05	0.000322	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LIPC—type 2 diabetes mellitus	2.74e-05	0.000322	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	2.74e-05	0.000322	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HBA1—type 2 diabetes mellitus	2.74e-05	0.000322	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCK—type 2 diabetes mellitus	2.74e-05	0.000322	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP11A1—type 2 diabetes mellitus	2.72e-05	0.00032	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.72e-05	0.00032	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.68e-05	0.000316	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.68e-05	0.000316	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC9A1—type 2 diabetes mellitus	2.68e-05	0.000315	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.67e-05	0.000314	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	2.67e-05	0.000314	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.66e-05	0.000313	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CETP—type 2 diabetes mellitus	2.65e-05	0.000311	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.63e-05	0.00031	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.59e-05	0.000305	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.58e-05	0.000304	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.55e-05	0.0003	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	2.55e-05	0.0003	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	2.55e-05	0.0003	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	2.55e-05	0.0003	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.48e-05	0.000291	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.46e-05	0.000289	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.46e-05	0.000289	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.46e-05	0.000289	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	2.44e-05	0.000287	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	2.44e-05	0.000287	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.43e-05	0.000285	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CTGF—type 2 diabetes mellitus	2.41e-05	0.000284	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.39e-05	0.000281	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	2.35e-05	0.000277	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	2.35e-05	0.000277	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.35e-05	0.000276	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.34e-05	0.000275	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.32e-05	0.000273	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	2.31e-05	0.000272	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.31e-05	0.000272	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.28e-05	0.000268	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	2.27e-05	0.000267	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	2.27e-05	0.000267	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	2.27e-05	0.000267	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.25e-05	0.000265	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—C3—type 2 diabetes mellitus	2.23e-05	0.000262	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	2.22e-05	0.000262	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.22e-05	0.000262	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.2e-05	0.000259	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.17e-05	0.000255	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	2.14e-05	0.000251	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	2.13e-05	0.000251	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.13e-05	0.000251	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.13e-05	0.00025	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.12e-05	0.00025	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.12e-05	0.000249	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.1e-05	0.000247	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.08e-05	0.000245	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.08e-05	0.000244	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.08e-05	0.000244	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.05e-05	0.000241	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.05e-05	0.000241	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	2e-05	0.000235	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2e-05	0.000235	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.96e-05	0.00023	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.93e-05	0.000227	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.93e-05	0.000227	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.93e-05	0.000227	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.93e-05	0.000227	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.86e-05	0.000218	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.85e-05	0.000218	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.85e-05	0.000218	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	1.84e-05	0.000216	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.84e-05	0.000216	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.83e-05	0.000215	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	1.81e-05	0.000212	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.8e-05	0.000212	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INS—type 2 diabetes mellitus	1.77e-05	0.000209	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.76e-05	0.000207	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	1.75e-05	0.000206	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.75e-05	0.000205	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.74e-05	0.000205	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.72e-05	0.000203	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.72e-05	0.000202	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.71e-05	0.000202	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.71e-05	0.000201	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.7e-05	0.0002	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	1.67e-05	0.000197	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.64e-05	0.000193	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	1.63e-05	0.000192	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.63e-05	0.000192	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	1.61e-05	0.000189	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	1.59e-05	0.000187	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	1.57e-05	0.000185	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	1.57e-05	0.000185	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.57e-05	0.000185	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.56e-05	0.000183	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.56e-05	0.000183	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	1.54e-05	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.54e-05	0.000181	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	1.53e-05	0.00018	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	1.53e-05	0.00018	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	1.53e-05	0.00018	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	1.53e-05	0.000179	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.51e-05	0.000177	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	1.5e-05	0.000176	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	1.48e-05	0.000174	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	1.48e-05	0.000174	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.46e-05	0.000172	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	1.43e-05	0.000168	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	1.41e-05	0.000166	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	1.4e-05	0.000165	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	1.39e-05	0.000163	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.38e-05	0.000162	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	1.38e-05	0.000162	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	1.38e-05	0.000162	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	1.38e-05	0.000162	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.35e-05	0.000159	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.34e-05	0.000157	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.33e-05	0.000157	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.32e-05	0.000155	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.32e-05	0.000155	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.31e-05	0.000154	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.31e-05	0.000154	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.26e-05	0.000148	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.25e-05	0.000147	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	1.24e-05	0.000146	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	1.24e-05	0.000146	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-05	0.000145	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-05	0.000144	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.21e-05	0.000143	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.21e-05	0.000142	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.21e-05	0.000142	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	1.2e-05	0.000141	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.19e-05	0.00014	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.19e-05	0.00014	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-05	0.000135	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-05	0.000132	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	1.1e-05	0.000129	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-05	0.000124	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-05	0.000124	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.03e-05	0.000121	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.03e-05	0.000121	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-05	0.000121	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.02e-05	0.00012	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.01e-05	0.000119	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-05	0.000119	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	9.81e-06	0.000115	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	9.61e-06	0.000113	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	9.54e-06	0.000112	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	9.37e-06	0.00011	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	9.17e-06	0.000108	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	9.14e-06	0.000107	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	8.9e-06	0.000105	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	8.79e-06	0.000103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	8.43e-06	9.92e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	8.27e-06	9.73e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	8.01e-06	9.42e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	7.88e-06	9.27e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	7.85e-06	9.23e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	7.76e-06	9.13e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.75e-06	9.12e-05	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.15e-06	8.41e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	6.84e-06	8.04e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	6.71e-06	7.89e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	6.15e-06	7.23e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	5.88e-06	6.92e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	5.88e-06	6.92e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	5.38e-06	6.33e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	4.83e-06	5.68e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.7e-06	3.18e-05	CbGpPWpGaD
